Low rates of chimerism occur when alemtuzumab is added to conditioning therapy for non-myeloablative allogeneic stem cell transplantation

Authors

• M Kasner

Publication/Presentation Date

2-2007

Volume

13

Issue

2

First Page

92

Last Page

92

Published In/Presented At

https://doi.org/10.1016/j.bbmt.2006.12.256

Disciplines

Medicine and Health Sciences

Department(s)

Hematology-Medical Oncology Division

Document Type

Article